Cybin (HELP) Cash from Financing Activities (2020 - 2025)

Cybin (HELP) reported Cash from Financing Activities of $14.6 million for Q1 2025, down 89.68% on a YoY basis from $141.6 million in Q1 2024, and up 11511.23% quarter-over-quarter from -$128137.0 in Q4 2024.

Cybin (HELP) Cash from Financing Activities (2020 - 2025) Analysis & Trends

Cybin has reported Cash from Financing Activities for 6 years, with the latest figure at $14.6 million in Q1 2025.

  • For the quarter ending Q1 2025, Cash from Financing Activities fell 89.68% year-over-year to $14.6 million; the trailing twelve-month figure through Mar 2025 stood at $14.1 million (down 92.55% YoY), and the FY2025 full-year result was $14.5 million, down 92.31% from the prior year.
  • Cash from Financing Activities for Q1 2025 stood at $14.6 million, up from -$128137.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $141.6 million in Q1 2024, with the low at -$26.8 million in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $13.3 million across 5 years, with a median of $2.5 million in 2022.
  • Annual changes were most pronounced in 2021 — Cash from Financing Activities jumped 4613.52% — and 2023, when it sank 1162.71%.
  • Cybin's Cash from Financing Activities stood at $1.1 million in 2021, then jumped by 129.43% to $2.5 million in 2022, then soared by 1045.56% to $29.2 million in 2023, then plunged by 100.44% to -$128137.0 in 2024, then soared by 11511.23% to $14.6 million in 2025.
  • The last three Cash from Financing Activities figures came in at $14.6 million (Q1 2025), -$128137.0 (Q4 2024), and -$271229.8 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Cybin 75.42 Mn 75.42 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 14.62 Mn
Mar 31, 2025 14.62 Mn
Dec 31, 2024 -128,137.00
Dec 31, 2024 -128,137.00
Sep 30, 2024 -271,229.76
Sep 30, 2024 -271,229.76
Jun 30, 2024 -171,818.03
Jun 30, 2024 -171,818.03
Mar 31, 2024 141.64 Mn
Mar 31, 2024 141.64 Mn
Dec 31, 2023 29.19 Mn
Dec 31, 2023 29.19 Mn
Sep 30, 2023 15.21 Mn
Sep 30, 2023 15.21 Mn
Jun 30, 2023 2.62 Mn
Jun 30, 2023 2.62 Mn
Feb 28, 2023 -26.81 Mn
Feb 28, 2023 -26.81 Mn
Dec 31, 2022 2.55 Mn
Dec 31, 2022 2.55 Mn